Medincell SA Capital Reinvestment Ratio
Medincell SA capital reinvestment ratio. Medincell SA (MEDCL) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow (€21.56 Million) in capital expenditures (€195.00K). Check MEDCL capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medincell SA (2016–2025)
Capital reinvestment ratio of Medincell SA from 2016 to 2025. This chart tracks Medincell SA's Capital Reinvestment Ratio across 2 annual periods. Also explore how fast is Medincell SA growing its equity to track the company's year-over-year net asset growth rate.
Medincell SA Capital Reinvestment Ratio by Year (2016–2025)
Medincell SA capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see MEDCL operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | €19.46 Million | €1.66 Million | ▼ -99.5% |
| 2016 | 17.12x | €68.00K | €1.16 Million | — |